McDonald's changes rules on Happy Meal orders Alleged drug boat from Venezuela turning back when hit, sources say Michael Douglas Shares Crazy Story Of Finding 11-Year-Old Drew Barrymore Waiting ...
The Association of Tutorial School Operators has suspended the Secretary of its Oyo State chapter, Ogundokun Olufunso, for calling for a five-year single term for registrars of the Joint Admissions ...
Hollow Knight: Silksong begins with Hornet being transported by some bugs to an unknown land before having to fight and ascend her way through Moss Grotto to discover where she is and just what is ...
China biotech RemeGen and its new U.S. partner Vor Bio are on a roll with their first-in-class autoimmune treatment telitacicept. Two weeks after RemeGen revealed the success of a China phase 3 trial ...
Founded by former OpenAI staff members and funded by Amazon and Google, Anthropic has raised the stakes in the GPT wars. Anthropic's Claude Desktop app often outshines its ChatGPT rival in various ...
German war-themed metal act Kanonenfieber have dropped their new single "Z-Vor!"" just in time for their early-hours set at Summer Breeze Open Air on Thursday night into Friday morning. The track ...
Vor Bio has handed Dallan Murray a swift return to the workforce. Weeks after being let go by Sarepta Therapeutics, Murray has landed the chief commercial officer post in Vor’s new-look C-suite.
Microsoft Flight Sim 2024 is now on the final approach for a year out in the wild. November will see the one year anniversary of the follow-up to the hugely successful Flight Simulator 2020 and, while ...
Star Trek: Strange New Worlds has many out-of-this-world elements, as a show set in the future about aliens and cosmic anomalies. However, many Trekkies agree that the perfectly coifed hair of one ...
Imagine this: you’re in the middle of an important project, juggling deadlines, and collaborating with a team scattered across time zones. Suddenly, your computer crashes, and hours of work vanish in ...
Vor Biopharma, a cancer cell therapy developer that laid off nearly all of its employees in a wind down of operations last month, has reemerged with new management, an in-licensed lead drug candidate, ...
Vor Biopharma Inc. VOR saw its stock climb Thursday following a strategic licensing agreement and a major capital raise to support its push into autoimmune therapies. The developments mark a pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results